Who is sponsoring NCT03495037?

NCT03495037 is sponsored by Baycrest.

What drugs are being tested in NCT03495037?

Interventions in NCT03495037: Real World Strategy Training, Psychosocial Education.

What condition does NCT03495037 study?

NCT03495037 studies Subjective Cognitive Decline.

Is NCT03495037 still recruiting?

NCT03495037 is currently completed. Last updated 21 July 2021.

Last reviewed 2021-07-21 · How we verify

NCT03495037

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preventing Cognitive and Functional Decline Among Seniors at Risk

Completed NA Last updated 21 July 2021

What this trial tests

NA trial testing Real World Strategy Training in Subjective Cognitive Decline in 232 participants. Completed in 30 March 2021.

Timeline

2 November 2017

Primary endpoint
30 March 2021

30 March 2021

Quick facts

Lead sponsor	Baycrest
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	232
Start date	2 November 2017
Primary completion	30 March 2021
Estimated completion	30 March 2021
Sites	1 location across Canada

Drugs / interventions tested

Real World Strategy Training
Psychosocial Education

Conditions studied

Subjective Cognitive Decline — all drugs for Subjective Cognitive Decline →

Sponsor

Baycrest — full company profile →

Who can join

Adults 60 to 85, any sex, with Subjective Cognitive Decline. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the efficacy of Real-World Strategy Training (RWST) compared to a psycho-education workshop for improving everyday life performance in older adults with subjective cognitive decline (SCD). Participants will be randomly assigned to receive one of these approaches.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Characterizing Cognition in Everyday Life of Older Adults With Subjective Cognitive Decline.
Rotenberg S, Dawson DR. · · 2022 · cited 8× · PMID 35499254 · DOI 10.1177/15394492221093310
Known-Groups and Convergent Validity of the Telephone Rey Auditory Verbal Learning Test total Learning Scores for Distinguishing Between Older Adults With Amnestic Cognitive Impairment and Subjective Cognitive Decline.
Jagtap S, Dawson DR, Vandermorris S, Anderson ND, et al · · 2021 · cited 6× · PMID 33067996 · DOI 10.1093/arclin/acaa085
Effectiveness of a Meta-Cognitive Group Intervention for Older Adults with Subjective Cognitive Decline or Mild Cognitive Impairment: The ASPIRE Randomized Controlled Trial.
Rotenberg S, Anderson ND, Binns MA, Skidmore ER, et al · · 2024 · cited 4× · PMID 39559867 · DOI 10.14283/jpad.2024.166
"It's better than nothing, but I do not find it to be ideal": Older adults' experience of TeleRehab during the first COVID-19 lockdown.
Rotenberg S, Oreper JS, Bar Y, Davids-Brumer N, et al · · 2023 · cited 3× · PMID 36471551 · DOI 10.1177/07334648221144022

Verify or expand the search:

Other trials of Real World Strategy Training

Trials testing the same drug.

NCT04439500 — Effects of Online Training Aimed at Increasing Participation in Everyday Life During a Pandemic (SCD Online). · NA · completed

Other recruiting trials for Subjective Cognitive Decline

Currently open trials in the same condition.

NCT07511270 — Prediction of Cognitive Test Performance Using AI-Based Analysis of Narrative Speech · NA · recruiting
NCT07085663 — Exergame-assisted Simultaneous Motor-cognitive Training for Middle-aged Old Adults in China · NA · recruiting
NCT06002477 — Attentional Mechanisms in SCD · EARLY_PHASE1 · recruiting
NCT06358404 — Developing a Peer Support Intervention for Depression in SCD · NA · recruiting
NCT06335836 — The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Su · recruiting

Other Baycrest trials

Trials by the same sponsor.

NCT06933667 — Kimel Family Centre for Brain Health and Wellness · NA · recruiting
NCT05509387 — Investigating if a Stronger tDCS Intensity is More Effective for Improving Naming Ability in People Living With Alzheime · NA · recruiting
NCT05508841 — Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation · NA · recruiting
NCT05347966 — Brain Health Support Program · NA · completed
NCT05167045 — A Pilot Study for the Brain Health Support Program · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03495037 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baycrest
Last refreshed: 21 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03495037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing